摘要
目的 观察复方麝香注射液对急性脑梗死患者血清C反应蛋白含量的影响，并分析其临床意义。方法 选择130例经颅脑CT或MRI确诊的急性脑梗死患者，随机分成两组，两组均予常规治疗，治疗组在此基础上加用复方麝香注射液20ml静脉滴注，分别在48h和治疗两周后测定两组患者的血清C反应蛋白的水平。结果 患者发病时血清C反应蛋白水平均增高，治疗组在治疗2周后，血清C反应蛋白水平明显降低与对照组相比有显著性差异（p〈0．05）。结论 复方麝香注射液可降低患者血清C反应蛋白水平，对脑梗死患者的病情变化、预后具有重要意义。
Objective To in investigate the effects of Compound Shexiang Injection on the contents of C-reaction protein （CRP） in Acute Ischemic Strock（AIS）. Methods 130 cases of AIS patients diagnosticated by CT or MRI were randomly divided into two groups： the control group were given normal therapy; the treatment group were added with infusing Compound Shexiang Injection at the base of the control group. And test the contests of CRP in both 48 hours and two weeks. Results The level of CRP of all the AIS patients rise just after the attact. The treatment with infusing Compound Shexiang Injection could obviously decrease the contents of CRP in two weeks（P〈0.05）. Conclusion Compound Shexiang Injection could decrease the contents of CRP. and is meaningful to the pathogenetic condition change and prognosis as well.
出处
《中华临床医学卫生杂志》
2006年第4期16-17,共2页
China Journal of Clinical Medicine Hygiene
关键词
复方麝香注射液
血清C反应蛋白
急性脑梗死
神经功能缺损
Compound shexiang injection C-reaction protein （CRP） Acute ischemic strock （AIS） Loss of neurologic function
